Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
8.93
↓ 83% below average
Average (9y)
52.17
Historical baseline
Range
High:287.76
Low:0.00
Volatility
551.6%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 8.93 | +724.2% |
| 2023 | 1.08 | -96.7% |
| 2022 | 33.02 | -72.0% |
| 2021 | 118.06 | +189.4% |
| 2020 | 40.79 | +287.0% |
| 2019 | 10.54 | -50.9% |
| 2018 | 21.47 | -92.5% |
| 2017 | 287.76 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |